University of Maryland/Greenebaum Cancer Center — Baltimore, Maryland

University of Maryland/Greenebaum Cancer Center is a clinical research site located in Baltimore, Maryland, United States 21201.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Maryland/Greenebaum Cancer Center has participated in 287 clinical trials with 153 currently active.

Therapeutic areas: Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor, FIGO Stage II Gestational Trophoblastic Tumor.

Sponsors: GOG Foundation, National Cancer Institute (NCI), SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Maryland/Greenebaum Cancer Center?

University of Maryland/Greenebaum Cancer Center has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Maryland/Greenebaum Cancer Center conducted?

University of Maryland/Greenebaum Cancer Center has 287 clinical trials on record, with 153 currently active. Their work covers Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor, FIGO Stage II Gestational Trophoblastic Tumor.

Is University of Maryland/Greenebaum Cancer Center accredited by Crixeo Health?

University of Maryland/Greenebaum Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Maryland/Greenebaum Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.